Cargando…
Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
Background: Apolipoprotein C1 (APOC1) has been proved to play a critical role in gastric, breast, lung, and pancreatic cancer. However, the relationship between APOC1 and urinary tumors remains unclear. This study aimed to assess the diagnostic and prognostic value of APOC1 in urinary tumors. Method...
Autores principales: | Cui, Yankang, Miao, Chenkui, Hou, Chao, Wang, Zengjun, Liu, Bianjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468425/ https://www.ncbi.nlm.nih.gov/pubmed/32974161 http://dx.doi.org/10.3389/fonc.2020.01436 |
Ejemplares similares
-
Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma
por: Cui, Yankang, et al.
Publicado: (2021) -
Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance
por: Xiao, Huaying, et al.
Publicado: (2021) -
Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer
por: Shi, Xiu, et al.
Publicado: (2020) -
Effects of VEGF and VEGFR polymorphisms on the outcome of patients with metastatic renal cell carcinoma treated with sunitinib: a systematic review and meta-analysis
por: Miao, Chenkui, et al.
Publicado: (2017) -
High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)